Scienture Holdings, Inc.
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. Th… Read more
Scienture Holdings, Inc. (SCNX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.039x
Based on the latest financial reports, Scienture Holdings, Inc. (SCNX) has a cash flow conversion efficiency ratio of -0.039x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.21 Million) by net assets ($82.67 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Scienture Holdings, Inc. - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Scienture Holdings, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Scienture Holdings, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Scienture Holdings, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Australian Vintage Ltd
PINK:AUVGF
|
0.001x |
|
Yuan Jen Enterprises Co Ltd
TW:1725
|
0.071x |
|
NSE S.A. EO 155
F:7YM
|
N/A |
|
Baird Medical Investment Holdings Limited
NASDAQ:BDMD
|
-0.090x |
|
Renalytix AI
NASDAQ:RNLX
|
0.996x |
|
Archer Entertainment Media Communications Inc.
PINK:CBLO
|
0.413x |
|
Central Motek Co Ltd
KO:308170
|
0.139x |
|
MARKEL CORP (MKV.SG)
STU:MKV
|
0.050x |
Annual Cash Flow Conversion Efficiency for Scienture Holdings, Inc. (2006–2024)
The table below shows the annual cash flow conversion efficiency of Scienture Holdings, Inc. from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $79.07 Million | $-14.27 Million | -0.180x | +95.60% |
| 2023-12-31 | $542.35K | $-2.23 Million | -4.103x | +10.09% |
| 2022-12-31 | $342.87K | $-1.56 Million | -4.563x | -570.44% |
| 2021-12-31 | $3.77 Million | $-2.57 Million | -0.681x | -166.73% |
| 2020-12-31 | $8.68 Million | $-2.21 Million | -0.255x | -845.21% |
| 2019-12-31 | $4.14 Million | $141.78K | 0.034x | -89.42% |
| 2018-12-31 | $844.67K | $273.39K | 0.324x | +158.81% |
| 2017-12-31 | $-311.93K | $171.67K | -0.550x | -148.11% |
| 2016-12-31 | $-1.15 Million | $-1.31 Million | 1.144x | +115.48% |
| 2015-12-31 | $267.02K | $-1.97 Million | -7.392x | -364.14% |
| 2014-12-31 | $668.44K | $-1.06 Million | -1.593x | +75.32% |
| 2013-12-31 | $130.87K | $-844.58K | -6.454x | -1200.16% |
| 2008-12-31 | $-48.01 Million | $-28.16 Million | 0.587x | -32.41% |
| 2007-12-31 | $-18.51K | $-16.07K | 0.868x | +234.87% |
| 2006-12-31 | $9.67K | $-6.22K | -0.644x | -- |